Background: Cancer research is highly dependent of large amount of data and high quality samples which can be provided by networks to enable large-scale multi-center research projects. Biologic materials, such as blood, tissue samples, DNA, body fluids and the related data obtained in cohorts and clinical trials are valuable sources for research which should be managed by policies and standard operating procedures as biorepositories or biobanks. Methods and evidence acquisition: The authors investigated and summarized pubmed database articles using biobanks and describing the policies. Conclusion: biobanking as a young discipline in different countries needs new technologies, standards and harmonization. In this review article, we have an...
The first biobank in Russia was created in 1998 to investigate post-Chernobyl thyroid tumors. The nu...
Background: Today's translational cancer research increasingly depends on international multi-center...
According to the National Cancer Institute, the lack of standardized, high-quality biospecimens is o...
Translational cancer research is highly dependent of large series of cases including high quality sa...
Biorespositories of formalin-fixed and paraffin-embedded (FFPE) or fresh frozen human tissues from m...
Biobanks provide a platform for innovative biomedical research and has improvised translational and ...
The progress in translational cancer research relies on access to well-characterized samples from a ...
Abstract Background. The availability of quality assured, population-based cancer registries and bio...
Background. The availability of quality assured, population-based cancer registries and biobanks wit...
Medical research increasingly relies on collections of donated human tissue, such as DNA samples, bl...
Sub-Saharan Africa has one of the highest incidences of infection with HIV globally, but more people...
Human biospecimen samples (HBS) and associated data stored in biobanks (also called "biotrusts," "bi...
Approximately, 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Canc...
Tumorbank@UZA is an academic hospital integrated biobank that collects tissue, blood and urine sampl...
The possibility of preserving human tissue separated from the body, from which to extract clinical i...
The first biobank in Russia was created in 1998 to investigate post-Chernobyl thyroid tumors. The nu...
Background: Today's translational cancer research increasingly depends on international multi-center...
According to the National Cancer Institute, the lack of standardized, high-quality biospecimens is o...
Translational cancer research is highly dependent of large series of cases including high quality sa...
Biorespositories of formalin-fixed and paraffin-embedded (FFPE) or fresh frozen human tissues from m...
Biobanks provide a platform for innovative biomedical research and has improvised translational and ...
The progress in translational cancer research relies on access to well-characterized samples from a ...
Abstract Background. The availability of quality assured, population-based cancer registries and bio...
Background. The availability of quality assured, population-based cancer registries and biobanks wit...
Medical research increasingly relies on collections of donated human tissue, such as DNA samples, bl...
Sub-Saharan Africa has one of the highest incidences of infection with HIV globally, but more people...
Human biospecimen samples (HBS) and associated data stored in biobanks (also called "biotrusts," "bi...
Approximately, 14.1 million new cancer cases and 8.2 million deaths occurred in 2012 worldwide. Canc...
Tumorbank@UZA is an academic hospital integrated biobank that collects tissue, blood and urine sampl...
The possibility of preserving human tissue separated from the body, from which to extract clinical i...
The first biobank in Russia was created in 1998 to investigate post-Chernobyl thyroid tumors. The nu...
Background: Today's translational cancer research increasingly depends on international multi-center...
According to the National Cancer Institute, the lack of standardized, high-quality biospecimens is o...